MedDay
Therapeutics for the treatment of neuro-metabolic diseases
MedDay has raised €34M across 1 funding round from 3 investors, most recently a Series B round in Apr 2016. Based in Paris, France; founded 2011; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€34M
€34,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2016-04
latest 2016-04
Funding by year
EUR raised per yearMedDay — funding by year — interactive chart.
Data table
| MedDay — funding by year | |
|---|---|
| 2016 | €34M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-04-01 | Series B | €34M | Bpifrance,Edmond de Rothschild Venture Capital,Sofinnova Partners | View deal → |
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData